Blood Testing Market Size

Blood Testing Market size was valued at USD 95.94 Billion in 2023 and is poised to grow from USD 103.14 Billion in 2024 to USD 183.94 Billion by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).

Growing medical spending through the government and private regulatory bodies is a major factor expected to bring an extensive growth in the global blood testing market during the forecast period. Multinational healthcare organisations are focusing in the discovery of new emerging techniques and promote awareness about the chronic disorders as well as eradication. Introduction to constructive regulatory parameters have a positive impact to promote the usage of POC testing.

A rapid growth in the prevalence of chronic disease along with the high demand for products for assessment of health conditions is projected to offer a significant momentum to the market in the coming years. Several operational entities in the global blood testing market is expected to gain lucrative opportunities as blood testing is integral for the regular monitoring of diseases. According to International Diabetes Federation, approximately 537 million adults have diabetes in 2019, and this number is expected to rise to 643 million by 2031 and 783 million by 2031. Due to this rapid increase in the number of diabetes patients, the demand for blood testing is expected to increase with a strong rate.

Regulatory bodies such as Centers for Medicare and Medicaid Services (CMS), FDA, and Federal Trade Commission play a crucial role in the regulation of diagnostic tests. These regulatory bodies have taken initiatives to commercialize Clinical Laboratory Improvement Amendments (CLIA) complaint diagnostic tests that can aid in early detection of diseases.

US Blood Testing Market  is poised to grow at a sustainable CAGR for the next forecast year.